Xylem Inc. Reports Steady Q1 FY2026: Revenue and EPS Beat Estimates, Guidance Maintained
Xylem Inc. (XYL) reported a steady Q1 FY2026, with both revenue and EPS beating estimates. The company's disciplined approach to operational efficiency and strategic capital deployment is evident, but the cautious guidance reflects a prudent stance in an uncertain macro environment.
Xylem Inc. reported revenue of $2,125.0 million for Q1 FY2026, surpassing the street estimate of $2,109.9 million, representing a 0.7% surprise. The company's EPS of $1.12 also exceeded the estimate of $1.08, with a surprise of +3.7%. This performance is in line with the company's historical trend of consistent, albeit modest, growth.
Despite the revenue being flat compared to the prior year, the company's gross margin improved to 37.8%, up 20 basis points from the prior year.
The company's EBITDA margin of 20.6% is a significant achievement, especially considering the challenging macroeconomic conditions. The improvement in margins is driven by a combination of price realization, productivity gains, and favorable mix, which offset the impact of inflation and volume headwinds.
Xylem maintained its full-year guidance, with adjusted EPS expected to range from $5.35 to $5.60. Despite the benefit from share repurchases, the company has chosen to keep its EPS range unchanged, reflecting a prudent approach to guidance.
The company expects second-quarter EPS to range from $1.31 to $1.36, driven by continued operational efficiency and price realization. William Grogan stated: "These results will yield second quarter EPS of $1.31 to $1.36." This guidance suggests that the company is well-positioned to navigate the current economic landscape and deliver consistent financial performance.
Xylem's operational performance in Q1 FY2026 was marked by a strong backlog and book-to-bill ratio. The company's ending backlog increased sequentially to $4.7 billion, and the book-to-bill ratio was above 1, indicating strong demand.
In the Measurement & Control Solutions segment, the book-to-bill ratio was below 1, but the backlog remained flat sequentially at approximately $1.4 billion. Orders were up a strong 15%, driven by smart metering demand in water.
The company's EBITDA margin in the Measurement & Control Solutions segment was 20.9%, 10 basis points lower than the prior year, driven by unfavorable mix and inflation, offset partly by productivity and price. This segment's performance underscores the company's ability to manage costs and maintain profitability in a challenging environment.
Xylem continues to focus on strategic capital deployment and share repurchases to enhance shareholder value. In February, the company announced a new $1.5 billion share repurchase authorization, executing on $581 million in Q1. Matthew Pine stated: "In February, we announced a new $1.5 billion share repurchase authorization, executing on $581 million in quarter 1."
The company is progressing towards its $1 billion annual target, optimizing its portfolio and leveraging its balance sheet. This strategic approach to capital allocation is expected to drive long-term value creation for shareholders.
Xylem's performance in Q1 FY2026 was influenced by various macroeconomic factors, particularly in China. The company saw a 30% year-over-year decline in China, which Matthew Pine acknowledged: "And you've heard us talk a lot about China and we've signaled that in the past, and we were down 30% year-over-year in China." Despite this headwind, the company remains focused on its long-term growth initiatives.
The company's revenue growth is expected to be in the 2% to 3% range on a reported basis and roughly 1% organically. This guidance reflects the company's cautious approach in an uncertain macro environment.
Xylem's performance in Q1 FY2026 has implications for its key customers and suppliers. The company's focus on ultrapure water treatment systems for Intel remains a critical component of its business. The decline in China may have a read-through effect on Intel's operations, particularly in regions where Xylem's presence is significant.
The company's strategic focus on capital deployment and M&A is expected to enhance its competitive position and drive long-term growth. Matthew Pine noted: "I think in my opening remarks, and I've said this in the past, we talk about $1 billion of capital deployment towards M&A. -- to help us get to the kind of mid-teens EPS growth that we outlined at our Investor Day back in 2024."
Comparing Xylem's performance to its peers in the Fab_Subsystems subsector, the company's gross margin of 37.8% is competitive. Among the peers, 6856.T has the highest gross margin at 43.8%, followed by 6370.T at 40.0%. Xylem's revenue growth of 2.7% YoY is in line with the peer group, with 6856.T leading with a 17.6% YoY growth.
Xylem's performance in Q1 FY2026 is consistent with its peers, but the company's focus on operational efficiency and strategic capital deployment sets it apart. The company's guidance and outlook reflect a balanced approach to navigating the current economic landscape.
The tone of Xylem's Q1 FY2026 earnings call was generally positive, with a sentiment score of 0.26, a slight improvement from the previous quarter. The guidance tone, however, was slightly less positive, with a score of 0.32, down from 0.40 in the previous quarter. The prepared sentiment score improved to 0.46, up from 0.37, indicating a more optimistic prepared statement.
The AI optimism score saw a significant increase to 0.90, up from 0.11 in the previous quarter, reflecting a more positive outlook on the company's future. The uncertainty index decreased by 21.1 points, and the QA evasiveness index dropped by 41.1 points, suggesting a more transparent and direct approach to answering investor questions.
For a detailed history of the company's call delivery, refer to the tone history.
Xylem Inc. reported a solid Q1 FY2026, with revenue and EPS beating estimates. The company's disciplined approach to operational efficiency and strategic capital deployment is evident, but the cautious guidance reflects a prudent stance in an uncertain macro environment. The strong backlog and book-to-bill ratio, coupled with a focus on capital deployment and M&A, position Xylem well for long-term growth. The company's performance is consistent with its peers, and the positive tone of the earnings call suggests a confident outlook for the future.